MX2021004383A - Composiciones y metodos para la estimulacion ovarica controlada. - Google Patents

Composiciones y metodos para la estimulacion ovarica controlada.

Info

Publication number
MX2021004383A
MX2021004383A MX2021004383A MX2021004383A MX2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A
Authority
MX
Mexico
Prior art keywords
methods
compositions
ovarian stimulation
controlled ovarian
controlled
Prior art date
Application number
MX2021004383A
Other languages
English (en)
Inventor
Lisbeth Helmgaard
Bjarke Mirner Klein
Saez Joan - Carles Arce
Patrick Heiser
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2021004383A publication Critical patent/MX2021004383A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos que usan y composiciones que incluyen FSH para usarse en el tratamiento de la infertilidad, en los que la dosis se selecciona basándose en la edad de la paciente para optimizar la eficacia acumulativa y/o reducir el riesgo de OHSS.
MX2021004383A 2018-10-17 2019-10-17 Composiciones y metodos para la estimulacion ovarica controlada. MX2021004383A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746812P 2018-10-17 2018-10-17
EP18203167 2018-10-29
PCT/EP2019/078170 WO2020079127A1 (en) 2018-10-17 2019-10-17 Compositions and methods for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
MX2021004383A true MX2021004383A (es) 2021-06-04

Family

ID=68344788

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021004383A MX2021004383A (es) 2018-10-17 2019-10-17 Composiciones y metodos para la estimulacion ovarica controlada.

Country Status (18)

Country Link
US (1) US20210353717A1 (es)
EP (1) EP3866833A1 (es)
JP (1) JP2022505191A (es)
KR (1) KR20210079276A (es)
CN (1) CN112789053A (es)
AU (1) AU2019363279A1 (es)
BR (1) BR112021005019A2 (es)
CA (1) CA3110205A1 (es)
CL (2) CL2021000928A1 (es)
CO (1) CO2021005872A2 (es)
IL (1) IL280750A (es)
JO (1) JOP20210025A1 (es)
MA (1) MA53909A (es)
MX (1) MX2021004383A (es)
PH (1) PH12021550417A1 (es)
SG (1) SG11202102340RA (es)
TW (1) TW202027780A (es)
WO (1) WO2020079127A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6856819B2 (ja) 2017-09-01 2021-04-14 フェリング ベスローテン フェンノートシャップ 調節卵巣刺激のための組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2356895T3 (es) * 2001-09-12 2011-04-14 Merck Serono Sa USO DE LA hCG Y LH EN LA HIPERESTIMULACIÓN OVÁRICA CONTROLADA.
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
MA53909A (fr) 2022-01-26
EP3866833A1 (en) 2021-08-25
US20210353717A1 (en) 2021-11-18
CL2022000779A1 (es) 2022-11-25
TW202027780A (zh) 2020-08-01
BR112021005019A2 (pt) 2021-06-08
CN112789053A (zh) 2021-05-11
KR20210079276A (ko) 2021-06-29
IL280750A (en) 2021-04-29
SG11202102340RA (en) 2021-05-28
CA3110205A1 (en) 2020-04-23
JP2022505191A (ja) 2022-01-14
WO2020079127A1 (en) 2020-04-23
AU2019363279A1 (en) 2021-03-11
CO2021005872A2 (es) 2021-09-20
PH12021550417A1 (en) 2021-09-20
CL2021000928A1 (es) 2021-10-22
JOP20210025A1 (ar) 2021-02-07

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
MX2020008244A (es) Composiciones y metodos para el tratamiento del cancer y de trastornos inmunitarios usando bacterias de veillonella.
MX2023007212A (es) Formulaciones de pulverizacion de epinefrina.
MX2021005398A (es) Terapia del cancer con celulas inmunitarias anti-cd33.
MX2019009190A (es) Uso de gaboxadol en el tratamiento de tinnitus.
PH12020551976A1 (en) SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONS
PH12021551036A1 (en) Anti-liv1 immune cell cancer therapy
CR20220329A (es) Anticuerpos anti–mertk y metodos de uso de los mismos
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2021013901A (es) Composiciones y métodos para el tratamiento del cáncer.
MX2021007885A (es) Metodos y composiciones para el tratamiento de trastornos de la piel y el cabello.
MX2021005400A (es) Terapia del cancer con celulas inmunitarias anti-ptk7.
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
JOP20210245A1 (ar) طرق لعلاج الداء النشواني من النوع خفيف السلسلة
PH12021550417A1 (en) Compositions and methods for controlled ovarian stimulation
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
MX2022005250A (es) Combinaciones terapeuticas de acalabrutinib y capivasertib para tratar neoplasias malignas de linfocitos b.
MX2021005751A (es) Anticuerpos contra mucina 16 y métodos de uso de los mismos.
WO2019190927A3 (en) Splice-switching oligonucleotides and methods of use
EA202190891A1 (ru) Композиции и способы для контролируемой стимуляции яичников
MX2022006883A (es) Uso de isatuximab para el tratamiento del mieloma multiple recidivante y/o refractario.
MD3675894T2 (ro) Compoziție pentru stimularea ovariană controlată
MX2022013895A (es) Derivados de bexaroteno y su uso en el tratamiento del cancer.